EE200000308A - Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid - Google Patents

Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid

Info

Publication number
EE200000308A
EE200000308A EEP200000308A EEP200000308A EE200000308A EE 200000308 A EE200000308 A EE 200000308A EE P200000308 A EEP200000308 A EE P200000308A EE P200000308 A EEP200000308 A EE P200000308A EE 200000308 A EE200000308 A EE 200000308A
Authority
EE
Estonia
Prior art keywords
protein
methods
hydrophobic moiety
hydrophobically modified
modified protein
Prior art date
Application number
EEP200000308A
Other languages
English (en)
Estonian (et)
Inventor
Pepinsky R. Blake
Zeng Chenhui
P. Baker Darren
Wen Dingyi
P. Williams Kevin
A. Garber Ellen
L. Strauch Kathryn
R. Taylor Frederick
H. Weinrub Paul
C. Petter Russell
Galdes Alphonse
Porter Jeffrey
Original Assignee
Biogen, Inc.
Ontogeny, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc., Ontogeny, Inc. filed Critical Biogen, Inc.
Publication of EE200000308A publication Critical patent/EE200000308A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200000308A 1997-12-03 1998-12-03 Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid EE200000308A (et)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (fr) 1997-12-03 1998-12-03 Compositions a base de proteines modifiees sur le plan hydrophobe et procedes d'elaboration

Publications (1)

Publication Number Publication Date
EE200000308A true EE200000308A (et) 2001-10-15

Family

ID=27490628

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000308A EE200000308A (et) 1997-12-03 1998-12-03 Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid

Country Status (25)

Country Link
US (1) US6444793B1 (fr)
EP (1) EP1036092B1 (fr)
JP (1) JP4289788B2 (fr)
KR (1) KR20010032753A (fr)
CN (1) CN1294595A (fr)
AT (1) ATE295372T1 (fr)
AU (1) AU757497B2 (fr)
BR (1) BR9815142A (fr)
CA (1) CA2309806A1 (fr)
CZ (1) CZ20002008A3 (fr)
DE (1) DE69830192T2 (fr)
DK (1) DK1036092T3 (fr)
EA (1) EA003739B1 (fr)
EE (1) EE200000308A (fr)
ES (1) ES2243018T3 (fr)
HU (1) HUP0100535A3 (fr)
IL (2) IL136137A0 (fr)
IS (1) IS2163B (fr)
MX (1) MXPA00005494A (fr)
NO (1) NO20002789L (fr)
NZ (1) NZ504752A (fr)
PL (1) PL197833B1 (fr)
PT (1) PT1036092E (fr)
TR (1) TR200001612T2 (fr)
WO (1) WO1999028343A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312009A1 (fr) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh Mutant actif de proteine du herisson, son procede de preparation et son utilisation a des fins pharmaceutiques
CA2309806A1 (fr) 1997-12-03 1999-06-10 Biogen, Inc. Compositions a base de proteines modifiees sur le plan hydrophobe et procedes d'elaboration
US6897297B1 (en) 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP1557427A3 (fr) * 1998-04-30 2005-10-19 Curis, Inc. Conjugué de protein "hedgehog"
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
EP1133519B1 (fr) * 1998-11-02 2008-08-13 Curis, Inc. Antagonistes fonctionnels de l'activite hedgehog
CA2352570A1 (fr) * 1998-12-03 2000-06-22 Biogen, Inc. Procedes et compositions servant a traiter des troubles entrainant une excitotoxicite
EP1025861A1 (fr) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Compositions pharmaceutiques des Proteines Hedgehog rendues hydrophobes, et leur utilisation
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
IL149202A0 (en) 1999-11-05 2002-11-10 Biogen Inc Hedgehog fusion proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
EP1504111A4 (fr) * 2002-04-19 2005-11-23 California Inst Of Techn Bibliotheque de molecules d'acides nucleiques et de peptides dont les peptides contiennent des residus d'acides amines non naturels, et methodes de production associee
WO2006019904A1 (fr) 2004-07-14 2006-02-23 University Of Utha Research Foundation Compositions et utilisations liées à des nétrines
EP1862180A4 (fr) * 2005-03-25 2010-09-15 Takeda Pharmaceutical Agent prophylactique et therapeutique contre le cancer
CA2629346A1 (fr) * 2005-11-11 2007-05-18 Proteogen Bio S.R.L. Procede de conversion de proteines actives solubles dans l'eau en proteines actives hydrophobes, utilisation de celui-ci pour la preparation de couches monomoleculaires de proteines actives orientees et appareils comprenant celles-ci
WO2008057468A1 (fr) 2006-11-02 2008-05-15 Curis, Inc. Régulateurs à petites molécules organiques de la prolifération cellulaires
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
JP5576801B2 (ja) * 2008-02-21 2014-08-20 ダーマケア・ニューロサイエンス・インスティテュート Ｍｎｔｆペプチドの美容および皮膚科用製剤
WO2009108868A2 (fr) * 2008-02-27 2009-09-03 Radiomedix Inc. Dérivés hedgehog radiomarqués utilisés en imagerie et en thérapie
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924754B (zh) * 2015-12-30 2021-11-09 北京大学 聚氨基酸偶联物
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
EP3700556A2 (fr) 2017-10-25 2020-09-02 Janssen Pharmaceuticals, Inc. Compositions de peptides tau phosphorylés et leurs utilisations
MY206596A (en) 2019-02-08 2024-12-25 Janssen Pharmaceuticals Inc Method of safe administration of phosphorylated tau peptide vaccine
JP2023136614A (ja) * 2022-03-17 2023-09-29 三菱ケミカル株式会社 植物を用いたヘッジホッグタンパク質の製造方法
CN116983461B (zh) * 2023-03-14 2025-07-22 中国石油大学(华东) 基于脂质体修饰的止血海绵体系
CN116549713B (zh) * 2023-05-09 2025-06-13 浙江大学 一种兼具组织粘合和防粘连的手术贴片和其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
EP0966478A4 (fr) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Nouveaux polypeptides derives d'une proteine herisson
CA2309806A1 (fr) 1997-12-03 1999-06-10 Biogen, Inc. Compositions a base de proteines modifiees sur le plan hydrophobe et procedes d'elaboration

Also Published As

Publication number Publication date
CA2309806A1 (fr) 1999-06-10
EA003739B1 (ru) 2003-08-28
CZ20002008A3 (cs) 2001-11-14
WO1999028343A2 (fr) 1999-06-10
JP4289788B2 (ja) 2009-07-01
KR20010032753A (ko) 2001-04-25
WO1999028343A9 (fr) 1999-10-14
DE69830192T2 (de) 2006-01-12
HUP0100535A2 (hu) 2001-06-28
HK1030953A1 (en) 2001-05-25
PL341430A1 (en) 2001-04-09
AU1996699A (en) 1999-06-16
BR9815142A (pt) 2000-10-10
NO20002789L (no) 2000-08-02
EA200000605A1 (ru) 2000-12-25
IS5499A (is) 2000-05-15
DE69830192D1 (de) 2005-06-16
NO20002789D0 (no) 2000-05-31
ATE295372T1 (de) 2005-05-15
ES2243018T3 (es) 2005-11-16
IS2163B (is) 2006-11-15
AU757497B2 (en) 2003-02-20
CN1294595A (zh) 2001-05-09
MXPA00005494A (es) 2003-05-19
JP2001525336A (ja) 2001-12-11
TR200001612T2 (tr) 2001-01-22
IL136137A0 (en) 2001-05-20
US6444793B1 (en) 2002-09-03
PT1036092E (pt) 2005-09-30
EP1036092B1 (fr) 2005-05-11
HUP0100535A3 (en) 2003-09-29
IL136137A (en) 2009-09-22
DK1036092T3 (da) 2005-08-15
WO1999028343A3 (fr) 1999-08-12
NZ504752A (en) 2002-10-25
PL197833B1 (pl) 2008-04-30
EP1036092A2 (fr) 2000-09-20

Similar Documents

Publication Publication Date Title
EE200000308A (et) Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid
De Caro et al. Porcine pancreatic lipase. Completion of the primary structure
Kuhn et al. The cytoplasmic carboxy terminus of M13 procoat is required for the membrane insertion of its central domain
PT1309861E (pt) Arrays funcionais de proteinas
DE60144145D1 (de) Subtilisin-variante
EP1067182A3 (fr) Proteine secretoire ou proteine de membrane
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
ATE219380T1 (de) Vehikel zum einbringen von nukleinsäuren in zellen
ATE431834T1 (de) Prozess zur trennung von proteinen
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
Takishima et al. Amino acid sequences of two nonspecific lipid‐transfer proteins from germinated castor bean
DE60114018D1 (de) Von zellen präsentierte peptide
Harnett et al. Molecular cloning and demonstration of an aminopeptidase activity in a filarial nematode glycoprotein
WO1999028876A3 (fr) Compositions proteiniques modifiees de maniere hydrophobe et leurs procedes de fabrication
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
Kimura et al. Expressed protein ligation: a new tool for the biosynthesis of cyclic polypeptides
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
Bell et al. In vivo NH2-terminal acetylation of Sindbis virus proteins.
WO1999047673A3 (fr) Genes de proteines membranaires mammiferes isoles, et reactifs associes
WO2001096593A3 (fr) Nouvelles proteines motrices et procedes d'utilisation de ces proteines
WO2002012541A3 (fr) Nouvelles proteines moteurs et leurs procedes d'utilisation
DE60113660D1 (de) G-protein gekoppelter rezeptor
BR0213772A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
DE69837562D1 (de) Peptidstrukturen und deren anwendung in der diagnostik von herpes simplex virus typ 2